Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MRL Pharma Private Limited is an Indian pharmaceutical company headquartered in New Delhi, specializing in the development, manufacturing, and marketing of a diverse range of healthcare products. Established in 2013, the company's portfolio spans multiple therapeutic areas, including dermatology, gastroenterology, pain management, and nutritional supplements. Key commercial products include MRL Ultra for moderate to severe pain relief and Nexofast for the treatment of acid reflux and gastroesophageal disorders. The company is committed to innovation in the complex generics space and is actively exploring the development of new chemical entities (NCEs) for focused therapy areas. MRL Pharma operates manufacturing facilities that adhere to stringent quality control standards, providing human pharmaceuticals, medical devices, and specialized dermatological care. Through collaborations with healthcare providers and government agencies, the company aims to deliver high-quality, affordable medications to a global patient base.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MRL Pharma.